Zhang P - Search Results

1

Neoadjuvant camrelizumab (an anti-PD-1 antibody) plus chemotherapy or apatinib (a VEGFR-2 inhibitor) for initially unresectable stage II-III non-small-cell lung cancer: a multicentre, two-arm, phase 2 exploratory study.

Xia H, Zhang H, Ruan Z, Zhang H, Sun L, Chen H, Zhou Y, Zhang L, Bian D, Zhu X, Zhang J, Sun F, Yu H, Song N, Liu X, Zhu Y, Zhang H, He W, Chen J, Yang J, Chen G, Xie S, Tang D, Zhang X, Duan L, Zhao D, Li Q, Zhang P, Jiang G. Xia H, et al. Among authors: zhang l, zhang p, zhang j, zhang h, zhang x. Signal Transduct Target Ther. 2024 Jun 14;9(1):145. doi: 10.1038/s41392-024-01861-w. Signal Transduct Target Ther. 2024. PMID: 38871690 Free PMC article. Clinical Trial.

2

Long-term progression-free survival in an advanced lung adenocarcinoma patient harboring EZR-ROS1 rearrangement: a case report.

Dong L, Xia J, Zhang J, Zhang Y, Zhu N, Zhang P, Zhang Y, Zhang X, Li S. Dong L, et al. Among authors: zhang p, zhang j, zhang x, zhang y. BMC Pulm Med. 2018 Jan 23;18(1):13. doi: 10.1186/s12890-018-0585-9. BMC Pulm Med. 2018. PMID: 29361925 Free PMC article.

3

Pembrolizumab associated Stevens-Johnson syndrome with porokeratosis in a patient in the setting of primary hepatocellular carcinoma.

Zhang J, Zhang P, Xu QY, Zhu YT, Chen W, Ji C. Zhang J, et al. Among authors: zhang p. Australas J Dermatol. 2022 Feb;63(1):e71-e74. doi: 10.1111/ajd.13704. Epub 2021 Aug 31. Australas J Dermatol. 2022. PMID: 34463968

4

Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing.

Hu J, Zhang L, Xia H, Yan Y, Zhu X, Sun F, Sun L, Li S, Li D, Wang J, Han Y, Zhang J, Bian D, Yu H, Chen Y, Fan P, Ma Q, Jiang G, Wang C, Zhang P. Hu J, et al. Among authors: zhang l, zhang p, zhang j. Genome Med. 2023 Mar 3;15(1):14. doi: 10.1186/s13073-023-01164-9. Genome Med. 2023. PMID: 36869384 Free PMC article.

5

Does the number of cycles of neoadjuvant therapy affect the efficacy of neoadjuvant chemoimmunotherapy for non-small cell lung cancer in locally advanced stage? Retrospective experience based on a single center.

Zhu D, Huang Z, Xiao K, Bian D, Zhang J, Zhang Z, Zhu S, Yin L, Zhu J, Zhang P. Zhu D, et al. Among authors: zhang p, zhang j, zhang z. Asia Pac J Clin Oncol. 2024 Oct;20(5):643-651. doi: 10.1111/ajco.13971. Epub 2023 Jun 14. Asia Pac J Clin Oncol. 2024. PMID: 37313687

6

The impact of oncogenic driver mutations on neoadjuvant immunotherapy outcomes in patients with resectable non-small cell lung cancer.

Shen Z, Teng M, Han L, Bian D, Zhang J, Zhu X, Qing Y, Hu S, Chen Y, Yao W, Yu H, Zhang L, Zhang P. Shen Z, et al. Among authors: zhang l, zhang p, zhang j. Cancer Immunol Immunother. 2023 Dec;72(12):4235-4247. doi: 10.1007/s00262-023-03560-x. Epub 2023 Nov 6. Cancer Immunol Immunother. 2023. PMID: 37932425 Free PMC article.

7

Liraglutide promotes autophagy by regulating the AMPK/mTOR pathway in a rat remnant kidney model of chronic renal failure.

Xue L, Pan Z, Yin Q, Zhang P, Zhang J, Qi W. Xue L, et al. Among authors: zhang p, zhang j. Int Urol Nephrol. 2019 Dec;51(12):2305-2313. doi: 10.1007/s11255-019-02274-3. Epub 2019 Sep 17. Int Urol Nephrol. 2019. PMID: 31531806

8

PTPL1 suppresses lung cancer cell migration via inhibiting TGF-β1-induced activation of p38 MAPK and Smad 2/3 pathways and EMT.

Zhu N, Zhang XJ, Zou H, Zhang YY, Xia JW, Zhang P, Zhang YZ, Li J, Dong L, Wumaier G, Li SQ. Zhu N, et al. Among authors: zhang p, zhang xj, zhang yy, zhang yz. Acta Pharmacol Sin. 2021 Aug;42(8):1280-1287. doi: 10.1038/s41401-020-00596-y. Epub 2021 Feb 3. Acta Pharmacol Sin. 2021. PMID: 33536603 Free PMC article.

9

Correlations of peripheral blood neutrophil-lymphocyte ratio and lymphocyte-monocyte ratio with renal function and prognosis in patients with lupus nephritis.

Xue L, Shi Y, Zhang J, Pan Z, Yin Q, Xie L, Zhang P, Xue S. Xue L, et al. Among authors: zhang p, zhang j. Am J Transl Res. 2022 Jan 15;14(1):336-342. eCollection 2022. Am J Transl Res. 2022. PMID: 35173851 Free PMC article.

10

Crosstalk between the Akt/mTORC1 and NF-κB signaling pathways promotes hypoxia-induced pulmonary hypertension by increasing DPP4 expression in PASMCs.

Li Y, Yang L, Dong L, Yang ZW, Zhang J, Zhang SL, Niu MJ, Xia JW, Gong Y, Zhu N, Zhang XJ, Zhang YY, Wei XM, Zhang YZ, Zhang P, Li SQ. Li Y, et al. Among authors: zhang p, zhang sl, zhang j, zhang xj, zhang yy, zhang yz. Acta Pharmacol Sin. 2019 Oct;40(10):1322-1333. doi: 10.1038/s41401-019-0272-2. Epub 2019 Jul 17. Acta Pharmacol Sin. 2019. PMID: 31316183 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31,555 results

Search Page

Filters